The Amersham Anti-CHO HCP Antibody, Supernatant, 1 mg (29496740) is an antibody reagent for host cell protein risk mitigation in CHO-derived bioprocess samples. It is supplied as a 1 mg tube and is designed for orthogonal HCP quantification methods, including coverage analysis workflows.
Key Features
- Supernatant-focused CHO HCP antibody, designed for work with host cell proteins from CHO supernatant samples
- 1 mg tube format, matching the Cytiva ordering information for part 29496740
- Orthogonal HCP quantification support, providing an antibody reagent for methods beyond the standard ELISA workflow
- DIBE coverage analysis compatibility, supporting fluorescent-based differential in-blot electrophoresis workflows
- Affinity-based chromatography method support, adding flexibility for complementary HCP analysis approaches
- Shared antibody basis with the HCPQuant CHO ELISA kit, using the same polyclonal primary antibody approach for ELISA validation context
- CHO-K1 and CHO-S supernatant protein reactivity, supporting use across common CHO cell line backgrounds
Benefits
- Helps laboratories assess whether anti-HCP antibodies provide suitable coverage for process-specific CHO supernatant samples.
- Supports ELISA validation by enabling complementary coverage analysis alongside HCPQuant CHO ELISA workflows.
- Provides flexibility for laboratories using DIBE, affinity-based chromatography or other orthogonal HCP quantification methods.
- Helps reduce the risk of undetected CHO host cell proteins during biologics process development and purification assessment.
Why Choose the Amersham Anti-CHO HCP Antibody, Supernatant, 1 mg (29496740)?
Choose the Amersham Anti-CHO HCP Antibody, Supernatant, 1 mg (29496740) when you need a CHO supernatant HCP antibody reagent for orthogonal impurity analysis and coverage assessment. John Morris Group can help Australian laboratories source Amersham HCPQuant CHO products and confirm suitability for HCP risk mitigation workflows.
